

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | primary amino compound metabolic process (GO:1901160) | 4.99932073 |
| 2 | imidazole-containing compound metabolic process (GO:0052803) | 4.85560908 |
| 3 | regulation of sarcomere organization (GO:0060297) | 4.62461847 |
| 4 | protein-chromophore linkage (GO:0018298) | 4.60852587 |
| 5 | tryptophan catabolic process (GO:0006569) | 4.43944510 |
| 6 | indole-containing compound catabolic process (GO:0042436) | 4.43944510 |
| 7 | indolalkylamine catabolic process (GO:0046218) | 4.43944510 |
| 8 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 4.43542177 |
| 9 | indolalkylamine metabolic process (GO:0006586) | 4.42283731 |
| 10 | negative regulation of systemic arterial blood pressure (GO:0003085) | 4.39171609 |
| 11 | cilium or flagellum-dependent cell motility (GO:0001539) | 4.35715433 |
| 12 | kynurenine metabolic process (GO:0070189) | 4.34761664 |
| 13 | NAD biosynthetic process (GO:0009435) | 4.21065170 |
| 14 | negative regulation of mast cell activation (GO:0033004) | 4.09998293 |
| 15 | regulation of hippo signaling (GO:0035330) | 4.08255417 |
| 16 | serotonin metabolic process (GO:0042428) | 4.03318700 |
| 17 | adenosine metabolic process (GO:0046085) | 4.03296822 |
| 18 | platelet dense granule organization (GO:0060155) | 4.03233990 |
| 19 | indole-containing compound metabolic process (GO:0042430) | 4.00599519 |
| 20 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.92219579 |
| 21 | signal peptide processing (GO:0006465) | 3.86768175 |
| 22 | tryptophan metabolic process (GO:0006568) | 3.85502914 |
| 23 | positive regulation of insulin-like growth factor receptor signaling pathway (GO:0043568) | 3.78696767 |
| 24 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.63832530 |
| 25 | cellular biogenic amine biosynthetic process (GO:0042401) | 3.55368226 |
| 26 | reflex (GO:0060004) | 3.53593644 |
| 27 | retinal cone cell development (GO:0046549) | 3.52944194 |
| 28 | musculoskeletal movement (GO:0050881) | 3.50821460 |
| 29 | multicellular organismal movement (GO:0050879) | 3.50821460 |
| 30 | amine biosynthetic process (GO:0009309) | 3.49013575 |
| 31 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.45524066 |
| 32 | behavioral response to nicotine (GO:0035095) | 3.35844736 |
| 33 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.35295760 |
| 34 | postsynaptic membrane organization (GO:0001941) | 3.32823537 |
| 35 | phasic smooth muscle contraction (GO:0014821) | 3.31849627 |
| 36 | positive regulation of endothelial cell differentiation (GO:0045603) | 3.28428190 |
| 37 | photoreceptor cell maintenance (GO:0045494) | 3.20042586 |
| 38 | cytokine biosynthetic process (GO:0042089) | 3.16912713 |
| 39 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.14019632 |
| 40 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.14019632 |
| 41 | amino acid salvage (GO:0043102) | 3.11690220 |
| 42 | L-methionine salvage (GO:0071267) | 3.11690220 |
| 43 | L-methionine biosynthetic process (GO:0071265) | 3.11690220 |
| 44 | endosome to melanosome transport (GO:0035646) | 3.10843319 |
| 45 | endosome to pigment granule transport (GO:0043485) | 3.10843319 |
| 46 | tachykinin receptor signaling pathway (GO:0007217) | 3.10349287 |
| 47 | positive regulation of vasculogenesis (GO:2001214) | 3.06078548 |
| 48 | detection of light stimulus involved in visual perception (GO:0050908) | 3.01278033 |
| 49 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.01278033 |
| 50 | cellular response to sterol (GO:0036315) | 2.98646293 |
| 51 | sphingoid metabolic process (GO:0046519) | 2.94948394 |
| 52 | righting reflex (GO:0060013) | 2.92249119 |
| 53 | regulation of T cell tolerance induction (GO:0002664) | 2.90733959 |
| 54 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.89778564 |
| 55 | neural tube formation (GO:0001841) | 2.88824743 |
| 56 | cellular ketone body metabolic process (GO:0046950) | 2.83940867 |
| 57 | benzene-containing compound metabolic process (GO:0042537) | 2.83372363 |
| 58 | protein localization to cilium (GO:0061512) | 2.82516016 |
| 59 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.81891764 |
| 60 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.81270797 |
| 61 | positive regulation of mast cell degranulation (GO:0043306) | 2.81270797 |
| 62 | neuronal action potential (GO:0019228) | 2.80058739 |
| 63 | behavioral response to ethanol (GO:0048149) | 2.79348524 |
| 64 | cysteine metabolic process (GO:0006534) | 2.78861471 |
| 65 | regulation of sequestering of triglyceride (GO:0010889) | 2.75794072 |
| 66 | fucose catabolic process (GO:0019317) | 2.74334995 |
| 67 | L-fucose metabolic process (GO:0042354) | 2.74334995 |
| 68 | L-fucose catabolic process (GO:0042355) | 2.74334995 |
| 69 | aromatic amino acid family metabolic process (GO:0009072) | 2.73816847 |
| 70 | protein K48-linked deubiquitination (GO:0071108) | 2.73405389 |
| 71 | mitochondrial RNA metabolic process (GO:0000959) | 2.71184608 |
| 72 | regulation of vasculogenesis (GO:2001212) | 2.70600970 |
| 73 | regulation of endothelial cell differentiation (GO:0045601) | 2.69365514 |
| 74 | adaptation of signaling pathway (GO:0023058) | 2.67068060 |
| 75 | aromatic amino acid family catabolic process (GO:0009074) | 2.66518989 |
| 76 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.64346350 |
| 77 | methionine biosynthetic process (GO:0009086) | 2.63818800 |
| 78 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.61688916 |
| 79 | xenobiotic catabolic process (GO:0042178) | 2.61629798 |
| 80 | methionine metabolic process (GO:0006555) | 2.61152448 |
| 81 | cytokine metabolic process (GO:0042107) | 2.61082287 |
| 82 | tRNA methylation (GO:0030488) | 2.60046614 |
| 83 | sulfur amino acid biosynthetic process (GO:0000097) | 2.59538598 |
| 84 | G-protein coupled receptor internalization (GO:0002031) | 2.58721954 |
| 85 | autophagic vacuole fusion (GO:0000046) | 2.57462191 |
| 86 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.57329989 |
| 87 | response to misfolded protein (GO:0051788) | 2.57149909 |
| 88 | inner ear receptor stereocilium organization (GO:0060122) | 2.56558475 |
| 89 | auditory receptor cell stereocilium organization (GO:0060088) | 2.55501331 |
| 90 | cellular biogenic amine catabolic process (GO:0042402) | 2.53510658 |
| 91 | amine catabolic process (GO:0009310) | 2.53510658 |
| 92 | detection of mechanical stimulus involved in sensory perception (GO:0050974) | 2.53171092 |
| 93 | thyroid hormone metabolic process (GO:0042403) | 2.52001182 |
| 94 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 2.51471427 |
| 95 | phosphorelay signal transduction system (GO:0000160) | 2.50154634 |
| 96 | negative regulation of Rho protein signal transduction (GO:0035024) | 2.49385370 |
| 97 | sulfation (GO:0051923) | 2.49142865 |
| 98 | rhodopsin mediated signaling pathway (GO:0016056) | 2.48163379 |
| 99 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.48134771 |
| 100 | arginine catabolic process (GO:0006527) | 2.47903275 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VDR_22108803_ChIP-Seq_LS180_Human | 4.15544360 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.27323529 |
| 3 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 3.20432283 |
| 4 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.04886637 |
| 5 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 3.01310412 |
| 6 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.90921519 |
| 7 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.41281455 |
| 8 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.38606264 |
| 9 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.35776563 |
| 10 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.29331921 |
| 11 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.09596139 |
| 12 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.03809384 |
| 13 | P300_19829295_ChIP-Seq_ESCs_Human | 2.00682564 |
| 14 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.99831223 |
| 15 | STAT3_23295773_ChIP-Seq_U87_Human | 1.93841057 |
| 16 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.81597958 |
| 17 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.80769038 |
| 18 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.78975807 |
| 19 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.76798683 |
| 20 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.72259272 |
| 21 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.68646984 |
| 22 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.67326335 |
| 23 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.66564421 |
| 24 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.63547031 |
| 25 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.58271054 |
| 26 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.57656333 |
| 27 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.57018095 |
| 28 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.56563569 |
| 29 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.55952923 |
| 30 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.55952923 |
| 31 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.55947974 |
| 32 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.50243357 |
| 33 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.49328542 |
| 34 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.49220419 |
| 35 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.48523545 |
| 36 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.47597063 |
| 37 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.44903490 |
| 38 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.44903490 |
| 39 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.44221873 |
| 40 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.43649678 |
| 41 | TCF4_23295773_ChIP-Seq_U87_Human | 1.41059800 |
| 42 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.40996663 |
| 43 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.40746877 |
| 44 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.38080991 |
| 45 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.37587439 |
| 46 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.35961755 |
| 47 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.32250258 |
| 48 | RXR_22108803_ChIP-Seq_LS180_Human | 1.31223533 |
| 49 | TP53_16413492_ChIP-PET_HCT116_Human | 1.31139618 |
| 50 | FUS_26573619_Chip-Seq_HEK293_Human | 1.29958225 |
| 51 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.29912589 |
| 52 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.24997911 |
| 53 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.24734680 |
| 54 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.23910121 |
| 55 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.23639940 |
| 56 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.23244171 |
| 57 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.22153145 |
| 58 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.21297737 |
| 59 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.21098457 |
| 60 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.21098457 |
| 61 | CJUN_26792858_Chip-Seq_BT549_Human | 1.20568532 |
| 62 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.20523919 |
| 63 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.19675048 |
| 64 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.17949090 |
| 65 | AR_25329375_ChIP-Seq_VCAP_Human | 1.16853539 |
| 66 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.14279865 |
| 67 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.14255225 |
| 68 | KDM2B_26808549_Chip-Seq_REH_Human | 1.13935442 |
| 69 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.13840503 |
| 70 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.13669272 |
| 71 | EWS_26573619_Chip-Seq_HEK293_Human | 1.13173244 |
| 72 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.13108108 |
| 73 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 1.12861840 |
| 74 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.12478216 |
| 75 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.11478036 |
| 76 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.10097686 |
| 77 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.09983503 |
| 78 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.09718358 |
| 79 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.09142159 |
| 80 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.08250099 |
| 81 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.07990499 |
| 82 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.07339829 |
| 83 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.07271234 |
| 84 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.06672327 |
| 85 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.06568907 |
| 86 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.06275850 |
| 87 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.05637105 |
| 88 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.05109365 |
| 89 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.05109365 |
| 90 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.04635870 |
| 91 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.04511382 |
| 92 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.02717987 |
| 93 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02712708 |
| 94 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.02248922 |
| 95 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.01903090 |
| 96 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.01374835 |
| 97 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.01310609 |
| 98 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.00970831 |
| 99 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.00807613 |
| 100 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.00333221 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003195_calcinosis | 3.63385222 |
| 2 | MP0001501_abnormal_sleep_pattern | 3.53205555 |
| 3 | MP0003950_abnormal_plasma_membrane | 3.38400655 |
| 4 | MP0003136_yellow_coat_color | 3.21269264 |
| 5 | MP0005167_abnormal_blood-brain_barrier | 3.11168471 |
| 6 | MP0002736_abnormal_nociception_after | 2.84894384 |
| 7 | MP0002735_abnormal_chemical_nociception | 2.64304068 |
| 8 | MP0005423_abnormal_somatic_nervous | 2.62577619 |
| 9 | MP0002653_abnormal_ependyma_morphology | 2.50890923 |
| 10 | MP0003183_abnormal_peptide_metabolism | 2.49163042 |
| 11 | MP0005551_abnormal_eye_electrophysiolog | 2.46498117 |
| 12 | MP0005171_absent_coat_pigmentation | 2.32324905 |
| 13 | MP0001968_abnormal_touch/_nociception | 2.28250073 |
| 14 | MP0006054_spinal_hemorrhage | 2.27332934 |
| 15 | MP0004147_increased_porphyrin_level | 2.26984283 |
| 16 | MP0005084_abnormal_gallbladder_morpholo | 2.26073993 |
| 17 | MP0003646_muscle_fatigue | 2.21469419 |
| 18 | MP0005083_abnormal_biliary_tract | 2.17670607 |
| 19 | MP0003806_abnormal_nucleotide_metabolis | 2.16181995 |
| 20 | MP0005670_abnormal_white_adipose | 2.12381110 |
| 21 | MP0010368_abnormal_lymphatic_system | 2.04742992 |
| 22 | MP0003880_abnormal_central_pattern | 1.89224634 |
| 23 | MP0004043_abnormal_pH_regulation | 1.87632091 |
| 24 | MP0005085_abnormal_gallbladder_physiolo | 1.85793029 |
| 25 | MP0006082_CNS_inflammation | 1.80846042 |
| 26 | MP0005646_abnormal_pituitary_gland | 1.80636883 |
| 27 | MP0008872_abnormal_physiological_respon | 1.77399425 |
| 28 | MP0008995_early_reproductive_senescence | 1.66637828 |
| 29 | MP0006276_abnormal_autonomic_nervous | 1.63628754 |
| 30 | MP0001485_abnormal_pinna_reflex | 1.60265321 |
| 31 | MP0009046_muscle_twitch | 1.58834108 |
| 32 | MP0002332_abnormal_exercise_endurance | 1.56147039 |
| 33 | MP0009745_abnormal_behavioral_response | 1.54604001 |
| 34 | MP0009278_abnormal_bone_marrow | 1.53709952 |
| 35 | MP0005360_urolithiasis | 1.50506060 |
| 36 | MP0003724_increased_susceptibility_to | 1.47272268 |
| 37 | MP0003252_abnormal_bile_duct | 1.47020428 |
| 38 | MP0003045_fibrosis | 1.44489294 |
| 39 | MP0002734_abnormal_mechanical_nocicepti | 1.42774722 |
| 40 | MP0001764_abnormal_homeostasis | 1.41595052 |
| 41 | MP0005253_abnormal_eye_physiology | 1.39453246 |
| 42 | MP0003943_abnormal_hepatobiliary_system | 1.38391504 |
| 43 | MP0002928_abnormal_bile_duct | 1.36983742 |
| 44 | MP0002733_abnormal_thermal_nociception | 1.34833387 |
| 45 | MP0005595_abnormal_vascular_smooth | 1.34767044 |
| 46 | MP0002572_abnormal_emotion/affect_behav | 1.30748996 |
| 47 | MP0003638_abnormal_response/metabolism_ | 1.29455297 |
| 48 | MP0001970_abnormal_pain_threshold | 1.20598147 |
| 49 | MP0002138_abnormal_hepatobiliary_system | 1.20023876 |
| 50 | MP0009697_abnormal_copulation | 1.19721345 |
| 51 | MP0000230_abnormal_systemic_arterial | 1.18106937 |
| 52 | MP0003633_abnormal_nervous_system | 1.13761288 |
| 53 | MP0002638_abnormal_pupillary_reflex | 1.12674589 |
| 54 | MP0001486_abnormal_startle_reflex | 1.10084540 |
| 55 | MP0005410_abnormal_fertilization | 1.07716846 |
| 56 | MP0009764_decreased_sensitivity_to | 1.06599530 |
| 57 | MP0002938_white_spotting | 1.04880436 |
| 58 | MP0005377_hearing/vestibular/ear_phenot | 1.04149351 |
| 59 | MP0003878_abnormal_ear_physiology | 1.04149351 |
| 60 | MP0002148_abnormal_hypersensitivity_rea | 0.99338220 |
| 61 | MP0005266_abnormal_metabolism | 0.98735722 |
| 62 | MP0001986_abnormal_taste_sensitivity | 0.94567602 |
| 63 | MP0004142_abnormal_muscle_tone | 0.93607146 |
| 64 | MP0002168_other_aberrant_phenotype | 0.92348209 |
| 65 | MP0004085_abnormal_heartbeat | 0.89888323 |
| 66 | MP0008058_abnormal_DNA_repair | 0.87853072 |
| 67 | MP0002067_abnormal_sensory_capabilities | 0.86668864 |
| 68 | MP0002064_seizures | 0.86456507 |
| 69 | MP0004233_abnormal_muscle_weight | 0.85429350 |
| 70 | MP0000026_abnormal_inner_ear | 0.85204677 |
| 71 | MP0002272_abnormal_nervous_system | 0.84588694 |
| 72 | MP0002557_abnormal_social/conspecific_i | 0.83527720 |
| 73 | MP0004145_abnormal_muscle_electrophysio | 0.83144734 |
| 74 | MP0005174_abnormal_tail_pigmentation | 0.82757619 |
| 75 | MP0004133_heterotaxia | 0.82556816 |
| 76 | MP0005332_abnormal_amino_acid | 0.81746788 |
| 77 | MP0008961_abnormal_basal_metabolism | 0.80119320 |
| 78 | MP0000371_diluted_coat_color | 0.79905853 |
| 79 | MP0008004_abnormal_stomach_pH | 0.78805516 |
| 80 | MP0001984_abnormal_olfaction | 0.78401752 |
| 81 | MP0001664_abnormal_digestion | 0.77469274 |
| 82 | MP0010386_abnormal_urinary_bladder | 0.76891501 |
| 83 | MP0002184_abnormal_innervation | 0.74432175 |
| 84 | MP0000372_irregular_coat_pigmentation | 0.74226605 |
| 85 | MP0003718_maternal_effect | 0.74029809 |
| 86 | MP0003698_abnormal_male_reproductive | 0.73084806 |
| 87 | MP0003635_abnormal_synaptic_transmissio | 0.72692205 |
| 88 | MP0005376_homeostasis/metabolism_phenot | 0.72487901 |
| 89 | MP0000631_abnormal_neuroendocrine_gland | 0.72265719 |
| 90 | MP0001963_abnormal_hearing_physiology | 0.71354599 |
| 91 | MP0000465_gastrointestinal_hemorrhage | 0.70814259 |
| 92 | MP0003631_nervous_system_phenotype | 0.70485615 |
| 93 | MP0000249_abnormal_blood_vessel | 0.70030303 |
| 94 | MP0005395_other_phenotype | 0.68926969 |
| 95 | MP0005448_abnormal_energy_balance | 0.68560313 |
| 96 | MP0002229_neurodegeneration | 0.67252269 |
| 97 | MP0003879_abnormal_hair_cell | 0.67056761 |
| 98 | MP0005195_abnormal_posterior_eye | 0.66762845 |
| 99 | MP0004215_abnormal_myocardial_fiber | 0.66209446 |
| 100 | MP0004885_abnormal_endolymph | 0.64817329 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of alanine metabolism (HP:0010916) | 4.97849847 |
| 2 | Hyperalaninemia (HP:0003348) | 4.97849847 |
| 3 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 4.97849847 |
| 4 | Attenuation of retinal blood vessels (HP:0007843) | 4.94328424 |
| 5 | Congenital sensorineural hearing impairment (HP:0008527) | 4.60059468 |
| 6 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.29248413 |
| 7 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 4.27947257 |
| 8 | Pancreatic cysts (HP:0001737) | 3.80246570 |
| 9 | Abolished electroretinogram (ERG) (HP:0000550) | 3.67631228 |
| 10 | Increased cerebral lipofuscin (HP:0011813) | 3.56788129 |
| 11 | Genetic anticipation (HP:0003743) | 3.43715758 |
| 12 | Chronic hepatic failure (HP:0100626) | 3.43540804 |
| 13 | Congenital stationary night blindness (HP:0007642) | 3.39548973 |
| 14 | Increased corneal curvature (HP:0100692) | 3.36578432 |
| 15 | Keratoconus (HP:0000563) | 3.36578432 |
| 16 | Constricted visual fields (HP:0001133) | 3.31712566 |
| 17 | Molar tooth sign on MRI (HP:0002419) | 3.20210276 |
| 18 | Abnormality of midbrain morphology (HP:0002418) | 3.20210276 |
| 19 | Progressive cerebellar ataxia (HP:0002073) | 3.10555198 |
| 20 | Hyperventilation (HP:0002883) | 3.08178925 |
| 21 | Gaze-evoked nystagmus (HP:0000640) | 3.01667676 |
| 22 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.00292180 |
| 23 | Retinal dysplasia (HP:0007973) | 2.98630185 |
| 24 | Central scotoma (HP:0000603) | 2.96709928 |
| 25 | True hermaphroditism (HP:0010459) | 2.92340156 |
| 26 | Pancreatic fibrosis (HP:0100732) | 2.88840237 |
| 27 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.88582471 |
| 28 | Abnormality of macular pigmentation (HP:0008002) | 2.85153841 |
| 29 | Facial diplegia (HP:0001349) | 2.77270360 |
| 30 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.75531886 |
| 31 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.75531886 |
| 32 | Abnormal protein glycosylation (HP:0012346) | 2.75531886 |
| 33 | Abnormal glycosylation (HP:0012345) | 2.75531886 |
| 34 | Cerebellar dysplasia (HP:0007033) | 2.75327359 |
| 35 | Febrile seizures (HP:0002373) | 2.63289919 |
| 36 | Type I transferrin isoform profile (HP:0003642) | 2.61532461 |
| 37 | Cystic liver disease (HP:0006706) | 2.55852288 |
| 38 | Type 2 muscle fiber atrophy (HP:0003554) | 2.55571944 |
| 39 | Abnormality of binocular vision (HP:0011514) | 2.50955048 |
| 40 | Diplopia (HP:0000651) | 2.50955048 |
| 41 | Inability to walk (HP:0002540) | 2.48407854 |
| 42 | Clumsiness (HP:0002312) | 2.46837909 |
| 43 | Sclerocornea (HP:0000647) | 2.42462717 |
| 44 | Absent speech (HP:0001344) | 2.41066653 |
| 45 | Autoimmune thrombocytopenia (HP:0001973) | 2.40606059 |
| 46 | Portal hypertension (HP:0001409) | 2.37214805 |
| 47 | Type II lissencephaly (HP:0007260) | 2.34960788 |
| 48 | Nephronophthisis (HP:0000090) | 2.34746574 |
| 49 | Decreased central vision (HP:0007663) | 2.34742857 |
| 50 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.33032606 |
| 51 | Scotoma (HP:0000575) | 2.32092651 |
| 52 | Progressive inability to walk (HP:0002505) | 2.29858146 |
| 53 | Large for gestational age (HP:0001520) | 2.27334329 |
| 54 | Abnormality of the hepatic vasculature (HP:0006707) | 2.23607473 |
| 55 | Abnormality of the ischium (HP:0003174) | 2.14003534 |
| 56 | Hypoplastic ischia (HP:0003175) | 2.12857278 |
| 57 | Congenital hepatic fibrosis (HP:0002612) | 2.09577441 |
| 58 | Abnormality of the renal medulla (HP:0100957) | 2.08581637 |
| 59 | Areflexia of lower limbs (HP:0002522) | 2.07876842 |
| 60 | Ileus (HP:0002595) | 2.07684764 |
| 61 | Esophageal varix (HP:0002040) | 2.05581071 |
| 62 | Abnormality of the pons (HP:0007361) | 2.04385318 |
| 63 | Hemiparesis (HP:0001269) | 2.03866198 |
| 64 | Thyroid-stimulating hormone excess (HP:0002925) | 2.03353137 |
| 65 | Pendular nystagmus (HP:0012043) | 2.03283835 |
| 66 | Polydipsia (HP:0001959) | 2.02878062 |
| 67 | Abnormal drinking behavior (HP:0030082) | 2.02878062 |
| 68 | Birth length less than 3rd percentile (HP:0003561) | 2.02236998 |
| 69 | Proximal tubulopathy (HP:0000114) | 2.02092483 |
| 70 | Cone-rod dystrophy (HP:0000548) | 1.99237118 |
| 71 | Poikiloderma (HP:0001029) | 1.98329461 |
| 72 | Ketoacidosis (HP:0001993) | 1.97210257 |
| 73 | Tubular atrophy (HP:0000092) | 1.94859254 |
| 74 | Methylmalonic aciduria (HP:0012120) | 1.94624327 |
| 75 | Small hand (HP:0200055) | 1.94410645 |
| 76 | Muscle fiber atrophy (HP:0100295) | 1.93752869 |
| 77 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.93676894 |
| 78 | Generalized aminoaciduria (HP:0002909) | 1.93465253 |
| 79 | Hypoplasia of the pons (HP:0012110) | 1.91195949 |
| 80 | Failure to thrive in infancy (HP:0001531) | 1.90560408 |
| 81 | Choroideremia (HP:0001139) | 1.90000409 |
| 82 | Nephrogenic diabetes insipidus (HP:0009806) | 1.87553204 |
| 83 | Decreased circulating renin level (HP:0003351) | 1.86682319 |
| 84 | Abnormal biliary tract physiology (HP:0012439) | 1.86052989 |
| 85 | Bile duct proliferation (HP:0001408) | 1.86052989 |
| 86 | Photophobia (HP:0000613) | 1.83534217 |
| 87 | Intrahepatic cholestasis (HP:0001406) | 1.83225634 |
| 88 | Albinism (HP:0001022) | 1.82416675 |
| 89 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.81589212 |
| 90 | Severe visual impairment (HP:0001141) | 1.81436910 |
| 91 | Depressed nasal tip (HP:0000437) | 1.80306582 |
| 92 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.79132184 |
| 93 | Conjugated hyperbilirubinemia (HP:0002908) | 1.78359520 |
| 94 | Vacuolated lymphocytes (HP:0001922) | 1.78256867 |
| 95 | Type II diabetes mellitus (HP:0005978) | 1.77201886 |
| 96 | Hypoplasia of the iris (HP:0007676) | 1.73634540 |
| 97 | Abnormal ciliary motility (HP:0012262) | 1.72956883 |
| 98 | Opisthotonus (HP:0002179) | 1.72519366 |
| 99 | Chorioretinal atrophy (HP:0000533) | 1.70888372 |
| 100 | Conjunctival telangiectasia (HP:0000524) | 1.70833299 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 7.12767788 |
| 2 | TIE1 | 6.95503498 |
| 3 | INSRR | 3.52062679 |
| 4 | ACVR1B | 3.18753063 |
| 5 | BMPR1B | 2.98420258 |
| 6 | TRIM28 | 2.90035736 |
| 7 | CASK | 2.67886904 |
| 8 | TAOK3 | 2.66022194 |
| 9 | ADRBK2 | 2.53250136 |
| 10 | PIK3CG | 2.43052829 |
| 11 | GRK1 | 2.38163375 |
| 12 | MUSK | 2.12691712 |
| 13 | LATS1 | 2.01360159 |
| 14 | FER | 1.91553115 |
| 15 | STK38L | 1.80777418 |
| 16 | NUAK1 | 1.76720263 |
| 17 | NTRK3 | 1.58063591 |
| 18 | TGFBR1 | 1.50144825 |
| 19 | PDK2 | 1.29939242 |
| 20 | TNK2 | 1.23309224 |
| 21 | TEC | 1.22020555 |
| 22 | MAPK13 | 1.20487318 |
| 23 | ADRBK1 | 1.15831932 |
| 24 | KDR | 1.12467628 |
| 25 | PKN1 | 1.12358087 |
| 26 | STK39 | 1.12191734 |
| 27 | PRKD3 | 1.11922061 |
| 28 | CCNB1 | 1.11320554 |
| 29 | PINK1 | 1.03498555 |
| 30 | SIK3 | 1.02482021 |
| 31 | MAP4K2 | 1.00822314 |
| 32 | PRKCE | 0.92367649 |
| 33 | OXSR1 | 0.89915734 |
| 34 | BCKDK | 0.81775659 |
| 35 | PTK2B | 0.79422775 |
| 36 | WNK4 | 0.78972257 |
| 37 | FGR | 0.73181264 |
| 38 | STK38 | 0.64615772 |
| 39 | CDK9 | 0.62433429 |
| 40 | IRAK4 | 0.61920081 |
| 41 | CAMK2A | 0.59390628 |
| 42 | PIK3CA | 0.58923290 |
| 43 | DAPK2 | 0.58763849 |
| 44 | TNIK | 0.57859233 |
| 45 | MAP2K1 | 0.56682385 |
| 46 | BMPR2 | 0.56035158 |
| 47 | PRKD2 | 0.54788230 |
| 48 | CDK8 | 0.54155377 |
| 49 | SIK2 | 0.52168072 |
| 50 | PRKCH | 0.52104963 |
| 51 | MKNK2 | 0.50512145 |
| 52 | LIMK1 | 0.50492232 |
| 53 | ZAP70 | 0.50227205 |
| 54 | NEK6 | 0.49818650 |
| 55 | MARK3 | 0.48713884 |
| 56 | ARAF | 0.48623738 |
| 57 | MOS | 0.46755534 |
| 58 | EPHA4 | 0.46655097 |
| 59 | ERBB4 | 0.45480580 |
| 60 | FES | 0.43789866 |
| 61 | IKBKB | 0.42916758 |
| 62 | MAP3K9 | 0.41948531 |
| 63 | IRAK1 | 0.40174747 |
| 64 | MAPK15 | 0.39635547 |
| 65 | ZAK | 0.38320663 |
| 66 | MAP3K13 | 0.38145508 |
| 67 | STK3 | 0.37293960 |
| 68 | OBSCN | 0.35437885 |
| 69 | MAP3K3 | 0.35383558 |
| 70 | EIF2AK3 | 0.35066736 |
| 71 | ICK | 0.34227652 |
| 72 | PRKCQ | 0.32859082 |
| 73 | EPHB2 | 0.31767968 |
| 74 | NTRK2 | 0.31516408 |
| 75 | PRKCG | 0.31325593 |
| 76 | MATK | 0.29145958 |
| 77 | INSR | 0.29004666 |
| 78 | NEK1 | 0.27085404 |
| 79 | MAPKAPK3 | 0.26995579 |
| 80 | BCR | 0.26664625 |
| 81 | MAPKAPK2 | 0.26057092 |
| 82 | PBK | 0.25520904 |
| 83 | PRKCI | 0.25493084 |
| 84 | PRKACB | 0.25265462 |
| 85 | WNK3 | 0.24736849 |
| 86 | ERBB3 | 0.24593707 |
| 87 | CSNK1A1L | 0.24365332 |
| 88 | PRKCA | 0.23551241 |
| 89 | EGFR | 0.22813301 |
| 90 | MAP3K4 | 0.22647775 |
| 91 | PIM2 | 0.22156531 |
| 92 | PRKACA | 0.22051928 |
| 93 | CAMK1 | 0.20715888 |
| 94 | GRK7 | 0.19750451 |
| 95 | PRKG1 | 0.18574096 |
| 96 | CDK19 | 0.18401784 |
| 97 | DAPK1 | 0.18295017 |
| 98 | CAMK2B | 0.17163130 |
| 99 | PRKAA2 | 0.17010366 |
| 100 | TGFBR2 | 0.16678242 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.25794650 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.09556694 |
| 3 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.73183183 |
| 4 | Histidine metabolism_Homo sapiens_hsa00340 | 2.61437880 |
| 5 | ABC transporters_Homo sapiens_hsa02010 | 2.55880834 |
| 6 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.32568847 |
| 7 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.27051485 |
| 8 | Phototransduction_Homo sapiens_hsa04744 | 2.22924996 |
| 9 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.16193664 |
| 10 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 2.14730264 |
| 11 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.13926355 |
| 12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.09700188 |
| 13 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.08863769 |
| 14 | Taste transduction_Homo sapiens_hsa04742 | 2.08383113 |
| 15 | Nicotine addiction_Homo sapiens_hsa05033 | 1.96277131 |
| 16 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.94085436 |
| 17 | Morphine addiction_Homo sapiens_hsa05032 | 1.86248107 |
| 18 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.73802824 |
| 19 | Basal transcription factors_Homo sapiens_hsa03022 | 1.72297014 |
| 20 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.72152111 |
| 21 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.64483329 |
| 22 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.63182054 |
| 23 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.57655499 |
| 24 | Olfactory transduction_Homo sapiens_hsa04740 | 1.55452509 |
| 25 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.53925606 |
| 26 | Homologous recombination_Homo sapiens_hsa03440 | 1.49726318 |
| 27 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.49036419 |
| 28 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.48522972 |
| 29 | Sulfur relay system_Homo sapiens_hsa04122 | 1.46199970 |
| 30 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.44967545 |
| 31 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.34468573 |
| 32 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.31149679 |
| 33 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.29022831 |
| 34 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.26574111 |
| 35 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.25854719 |
| 36 | GABAergic synapse_Homo sapiens_hsa04727 | 1.25842337 |
| 37 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.20850419 |
| 38 | Other glycan degradation_Homo sapiens_hsa00511 | 1.19787107 |
| 39 | Retinol metabolism_Homo sapiens_hsa00830 | 1.19424701 |
| 40 | Circadian entrainment_Homo sapiens_hsa04713 | 1.18621113 |
| 41 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.16741993 |
| 42 | Peroxisome_Homo sapiens_hsa04146 | 1.13215466 |
| 43 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.06729724 |
| 44 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.05838276 |
| 45 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.05658617 |
| 46 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.04861984 |
| 47 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.03618058 |
| 48 | Mineral absorption_Homo sapiens_hsa04978 | 0.97142064 |
| 49 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.95689453 |
| 50 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.95615806 |
| 51 | Salivary secretion_Homo sapiens_hsa04970 | 0.95451945 |
| 52 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.92650456 |
| 53 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.90720222 |
| 54 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.88142944 |
| 55 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.85990249 |
| 56 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.83409797 |
| 57 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.79736899 |
| 58 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.76805809 |
| 59 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.76791207 |
| 60 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.73883164 |
| 61 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.72953904 |
| 62 | Asthma_Homo sapiens_hsa05310 | 0.71372327 |
| 63 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.71135679 |
| 64 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.70723248 |
| 65 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.69035131 |
| 66 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.67302719 |
| 67 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.66172064 |
| 68 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.64912167 |
| 69 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.64387156 |
| 70 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.64104675 |
| 71 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.61400900 |
| 72 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.61140459 |
| 73 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.60851381 |
| 74 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.60424745 |
| 75 | Legionellosis_Homo sapiens_hsa05134 | 0.59847391 |
| 76 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.57164059 |
| 77 | Lysosome_Homo sapiens_hsa04142 | 0.56924211 |
| 78 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.56119038 |
| 79 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.55392279 |
| 80 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.51560144 |
| 81 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.50803112 |
| 82 | Bile secretion_Homo sapiens_hsa04976 | 0.48670954 |
| 83 | Purine metabolism_Homo sapiens_hsa00230 | 0.48405859 |
| 84 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.48300288 |
| 85 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.47744923 |
| 86 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.47283955 |
| 87 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.46079842 |
| 88 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45257534 |
| 89 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.42969941 |
| 90 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.41447825 |
| 91 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.40324835 |
| 92 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.39433254 |
| 93 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.38282088 |
| 94 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.37175164 |
| 95 | Insulin secretion_Homo sapiens_hsa04911 | 0.37019051 |
| 96 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.34943400 |
| 97 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.34627653 |
| 98 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.31708565 |
| 99 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.29815264 |
| 100 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.29339506 |

